慢性阿片类药物使用对术后活动能力恢复和患者报告结局的影响:一项倾向性匹配研究
该研究为多中心前瞻性观察队列的二次数据分析,将153例术前慢性阿片类药物使用者与306例未使用者按2:1倾向性匹配,比较全髋或全膝关节置换术后90天活动能力。匹配队列中,阿片类药物使用组在术后3个月和6个月步数较低(4823 vs 5848,P=0.03),术前和术后6个月报告行走中度至极度困难的比例更高(80.6% vs 69.0%,P=0.02;19.2% vs 9.3%,P=0.01),但90天无辅助行走比例无显著差异(87.8% vs 90.7%,P=0.26)。结论认为术前慢性阿片类药物使用与术后主观和客观活动能力指标显著降低相关。
要点
- 匹配队列中,阿片类药物使用组术后3个月和6个月步数低于未使用组(4823 vs 5848,P=0.03)。
- 阿片类药物使用组术前和术后6个月报告行走中度至极度困难的比例均高于未使用组(80.6% vs 69.0%,P=0.02;19.2% vs 9.3%,P=0.01)。
- 匹配队列中90天无辅助行走比例两组无显著差异(87.8% vs 90.7%,P=0.26)。
核心结论
- 在匹配队列中,术前慢性阿片类药物使用者的术后活动能力主观和客观指标均显著降低。
- 即使考虑可能影响行走的基线因素后,术前慢性阿片类药物使用仍对关节置换术后客观活动能力指标产生负面影响。
研究设计与样本
- 研究为多中心前瞻性观察队列研究的二次数据分析,患者使用基于智能手机的管理平台配合智能手表进行自我导向康复。
- 153例术前慢性阿片类药物使用者与306例未使用者按2:1匹配,匹配因素包括年龄、体质指数、性别、手术类型、Charnley分级、行走状态、骨科手术史和焦虑。
- 术后活动能力结局包括90天患者报告的无辅助行走能力、步数以及5级EuroQol-5维度5水平问卷回答,采用卡方检验和学生t检验比较,并比较了未匹配队列以探究匹配的影响。
主要发现
- 匹配队列中,阿片类药物使用组与未使用组年龄(61.9±10.5 vs 62.1±10.3,P=0.90)和女性比例(53.6% vs 53.3%,P=0.95)相似。
- 匹配队列中,90天报告无辅助行走的比例两组无显著差异(87.8% vs 90.7%,P=0.26)。
- 步数在术前和术后1个月两组相似,但在术后3个月和6个月阿片类药物使用组较低(4823 vs 5848,P=0.03)。
- 在5级EuroQol-5维度5水平问卷中,更多阿片类药物使用者在术前报告行走中度至极度困难(80.6% vs 69.0%,P=0.02),术后6个月亦如此(19.2% vs 9.3%,P=0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Opioid use prior to total joint arthroplasty may be associated with poorer postoperative outcomes. However, few studies have reported the impact on postoperative recovery of mobility. We hypothesized that chronic opioid users would demonstrate impaired objective and subjective mobility recovery compared to nonusers. METHODS: A secondary data analysis of a multicenter, prospective observational cohort study in which patients used a smartphone-based care management platform with a smartwatch for self-directed rehabilitation following hip or knee arthroplasty was performed. Patients were matched 2:1 based on age, body mass index, sex, procedure, Charnley class, ambulatory status, orthopedic procedure history, and anxiety. Postoperative mobility outcomes were measured by patient-reported ability to walk unassisted at 90 days, step counts, and responses to the 5-level EuroQol-5 dimension 5-level, compared by Chi-square and student's t-tests. Unmatched cohorts were also compared to investigate the impact of matching. RESULTS: A total of 153 preoperative chronic opioid users were matched to 306 opioid-naïve patients. Age (61.9 ± 10.5 versus 62.1 ± 10.3, P = .90) and sex (53.6 versus 53.3% women, P = .95) were similar between groups. The proportion of people who reported walking unassisted for 90 days did not vary in the matched cohort (87.8 versus 90.7%, P = .26). Step counts were similar preoperatively and 1-month postoperatively but were lower in opioid users at 3 and 6 months postoperatively (4,823 versus 5,848, P = .03). More opioid users reported moderate to extreme problems with ambulation preoperatively on the 5-level EuroQol-5 dimension 5-level (80.6 versus 69.0%, P = .02), and at 6 months (19.2 versus 9.3%, P = .01). CONCLUSIONS: Subjective and objective measures of postoperative mobility were significantly reduced in patients who chronically used opioid medications preoperatively. Even after considering baseline factors that may affect ambulation, objective mobility metrics following arthroplasty were negatively impacted by preoperative chronic opioid use.
引用
- Nelson CL, Sheth NP, Higuera Rueda CA, et al. Impact of Chronic Opioid Use on Postoperative Mobility Recovery and Patient-Reported Outcomes: A Propensity-Matched Study. J Arthroplasty. 2024. PMID: 38401614. doi:10.1016/j.arth.2024.02.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。